Insufficient scRNA-seq data for expression of CALHM1 at single-cell level.
Insufficient scRNA-seq data for expression of CALHM1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 87% | 111.93 | 2303 / 2642 | 13% | 0.41 | 95 / 705 |
spleen | 95% | 15.99 | 229 / 241 | 0% | 0 | 0 / 0 |
ovary | 86% | 10.92 | 154 / 180 | 1% | 0.04 | 3 / 430 |
uterus | 84% | 11.06 | 142 / 170 | 1% | 0.03 | 5 / 459 |
adrenal gland | 56% | 12.01 | 145 / 258 | 24% | 1.33 | 56 / 230 |
bladder | 57% | 4.62 | 12 / 21 | 1% | 0.26 | 7 / 504 |
prostate | 56% | 5.43 | 136 / 245 | 0% | 0 | 0 / 502 |
lung | 52% | 4.94 | 301 / 578 | 2% | 0.06 | 18 / 1155 |
breast | 45% | 6.56 | 206 / 459 | 8% | 0.26 | 92 / 1118 |
adipose | 50% | 7.74 | 599 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 49% | 5.80 | 651 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 47% | 16.74 | 432 / 929 | 0% | 0 | 0 / 0 |
intestine | 41% | 9.50 | 395 / 966 | 1% | 0.09 | 5 / 527 |
esophagus | 35% | 5.23 | 510 / 1445 | 3% | 0.15 | 5 / 183 |
thymus | 33% | 4.77 | 217 / 653 | 2% | 0.15 | 12 / 605 |
stomach | 30% | 6.55 | 106 / 359 | 1% | 0.24 | 4 / 286 |
skin | 31% | 4.26 | 559 / 1809 | 0% | 0 | 0 / 472 |
lymph node | 0% | 0 | 0 / 0 | 21% | 8.88 | 6 / 29 |
heart | 19% | 1.50 | 166 / 861 | 0% | 0 | 0 / 0 |
kidney | 16% | 1.11 | 14 / 89 | 0% | 0.02 | 2 / 901 |
pancreas | 6% | 2.90 | 19 / 328 | 1% | 0.02 | 2 / 178 |
muscle | 7% | 1.39 | 54 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 2% | 0.03 | 1 / 45 |
liver | 1% | 0.11 | 3 / 226 | 0% | 0.01 | 2 / 406 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0051260 | Biological process | protein homooligomerization |
GO_0050917 | Biological process | sensory perception of umami taste |
GO_0015867 | Biological process | ATP transport |
GO_0034765 | Biological process | regulation of monoatomic ion transmembrane transport |
GO_0050913 | Biological process | sensory perception of bitter taste |
GO_0051291 | Biological process | protein heterooligomerization |
GO_0006812 | Biological process | monoatomic cation transport |
GO_1904669 | Biological process | ATP export |
GO_0050916 | Biological process | sensory perception of sweet taste |
GO_0070588 | Biological process | calcium ion transmembrane transport |
GO_0005886 | Cellular component | plasma membrane |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0016323 | Cellular component | basolateral plasma membrane |
GO_0005244 | Molecular function | voltage-gated monoatomic ion channel activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0005261 | Molecular function | monoatomic cation channel activity |
GO_0005245 | Molecular function | voltage-gated calcium channel activity |
GO_0005515 | Molecular function | protein binding |
GO_0005227 | Molecular function | calcium-activated cation channel activity |
Gene name | CALHM1 |
Protein name | Calcium homeostasis modulator protein 1 (Protein FAM26C) |
Synonyms | FAM26C |
Description | FUNCTION: Pore-forming subunit of a voltage-gated ion channel required for sensory perception of sweet, bitter and umami tastes (By similarity). Specifically present in type II taste bud cells, where it plays a central role in sweet, bitter and umami taste perception by inducing ATP release from the cell, ATP acting as a neurotransmitter to activate afferent neural gustatory pathways (By similarity). Together with CALHM3, forms a fast-activating voltage-gated ATP-release channel in type II taste bud cells (TBCs) (By similarity). Acts both as a voltage-gated and calcium-activated ion channel: mediates neuronal excitability in response to changes in extracellular Ca(2+) concentration . Has poor ion selectivity and forms a wide pore (around 14 Angstroms) that mediates permeation of Ca(2+), Na(+) and K(+), as well as permeation of monovalent anions . Acts as an activator of the ERK1 and ERK2 cascade . Triggers endoplasmic reticulum stress by reducing the calcium content of the endoplasmic reticulum . May indirectly control amyloid precursor protein (APP) proteolysis and aggregated amyloid-beta (Abeta) peptides levels in a Ca(2+) dependent manner . . |
Accessions | ENST00000329905.6 Q8IU99 |